Current status of immunotherapies for addiction.

Annals of the New York Academy of Sciences
Ashley Xu, Thomas R Kosten

Abstract

The treatment of substance use disorders has always been challenging because multiple neurotransmitters mediate addiction. However, with smoking being the leading cause of preventable death and the recent opioid epidemic in the United States, the search for novel solutions becomes more imperative. In this review, we discuss the use of antibodies to treat addictions and highlight areas of success and areas that require improvement, using examples from cocaine, nicotine, and opioid vaccines. Through each example, we examine creative problem-solving strategies for developing future vaccines, such as using an adenovirus vector as a carrier, designing bivalent vaccines, stimulating Toll-like receptors for adjuvant effects, and altering the route of administration. Our review also covers passive immunization alone to override or prevent drug toxicity as well as in combination with vaccines for more rapid and potentially greater efficacy.

References

Dec 13, 1985·JAMA : the Journal of the American Medical Association·R R RedfieldW H Bancroft
Oct 1, 1996·Nature Medicine·B S FoxT J Briner
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·C L Brazolot MillanH L Davis
Jul 30, 2002·Addiction·Gianluca QuaglioUNKNOWN Gruppo Intersert di Collaborazione Scientifica
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arnaud DidierlaurentJean-Claude Sirard
Nov 5, 2004·The New England Journal of Medicine·Richard T KenneyGregory M Glenn
Jun 3, 2005·Biological & Pharmaceutical Bulletin·Kolbrun HrafnkelsdottirSveinbjorn Gizurarson
Jul 26, 2005·Biological Psychiatry·Bridget A MartellThomas R Kosten
Aug 21, 2007·Experimental and Clinical Psychopharmacology·Elise M WeertsAmy K Goodwin
Jul 29, 2008·International Immunopharmacology·D E KeylerP R Pentel
Oct 15, 2008·Archives of Internal Medicine·Nancy A RigottiLindsay F Stead
Aug 28, 2010·Advances in Experimental Medicine and Biology·Monica Vaccari, Genoveffa Franchini
Jan 29, 2011·Clinical Pharmacology and Therapeutics·D K HatsukamiS I Rennard
Sep 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sunmee WeeGeorge F Koob
Mar 3, 2012·Molecular Pharmaceutics·Jennifer B Treweek, Kim D Janda
Dec 12, 2012·The Journal of Pharmacology and Experimental Therapeutics·M D RaleighP R Pentel
Mar 6, 2013·Neuroscience Letters·Thomas R KostenDavid A Nielsen
Mar 9, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Serena TonstadKarl-Olov Fagerström
May 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joel E SchlosburgGeorge F Koob
Jun 7, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Therese A KostenThomas R Kosten
Feb 13, 2014·Molecular Pharmaceutics·Paul T BremerKim D Janda
May 6, 2014·Drug and Alcohol Dependence·Thomas R KostenKyle Kampman
Dec 23, 2014·Molecular Pharmaceutics·Jonathan W LocknerKim D Janda
Feb 12, 2015·JAMA Psychiatry·Elizabeth Reisinger WalkerBenjamin G Druss
Mar 7, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rajeev I Desai, Jack Bergman
Nov 21, 2015·Journal of AIDS & Clinical Research·Jonathan D FuchsUNKNOWN NIAID HIV Vaccine Trials Network
Sep 30, 2017·Drug and Alcohol Dependence·William S John, Li-Tzy Wu
Jun 25, 2018·Neuropharmacology·Jacques D NguyenMichael A Taffe

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Vaccines
Margaret Haney, Thomas R Kosten
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Margaret A Liu
Annals of Translational Medicine
John NemunaitisLeah Plato
© 2021 Meta ULC. All rights reserved